Branded

ARLINGTON HEIGHTS, Ill. — Egg allergies may no longer be a valid reason to not get a flu shot, the American College of Allergy, Asthma and Immunology announced Friday. 

Amid an unusually strong flu season that the Centers for Disease Control and Prevention has called an epidemic, supplies of flu vaccines are running low, and some people hoping to get immunized are having trouble finding them.

WINSTON-SALEM, N.C. — According to a new study by researchers at Wake Forest Baptist Medical Center released Thursday, less than 45% of children were vaccinated against the flu during a five-year study period.

ATLANTA — The worst of the flu season may be over, at least for those on the East Coast. In a late morning press conference with reporters on Friday, Thomas Frieden, director of the Centers for Disease Control and Prevention, said, "We are seeing a decrease in some regions." 

Just don't tell that to anyone living in New York, Boston or Chicago, at least not before slipping on a facemask first.  

NEW YORK — A new drug for treating attention deficit hyperactivity disorder made by Pfizer is now available, the drug maker said.

Pfizer announced the availability of Quillivant XR (methylphenidate hydrochloride) extended-release oral suspension, calling it the first once-per-day, extended-release liquid formulation of methylphenidate. The Food and Drug Administration approved the drug in September 2012.

RARITAN, N.J. -- A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.

J&J said the FDA's Endocrinologic and Metabolic Drugs Advisory Committee had recommended approval for canagliflozin, which the company plans to market under the name brand Invokana. The FDA is not required to follow the votes of advisory committees when deciding whether or not to approve a drug, but usually does.

NEW YORK -- Growth in the consumer products market is likely to slow down over the next five years, while pharmacy retailers will see a profit windfall due to the generic drug cycle, according to a new report.

ATLANTA — The worst of the flu season may be over, at least for those in the South. In a late morning press conference with reporters, Thomas Frieden, director of the Centers for Disease Control and Prevention, said, "We are seeing a decrease in some regions."